Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CHD6 mRNA | decreases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CHD6 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CHD6 mRNA | decreases expression | 19150397
|
C014347 |
decitabine |
[decitabine affects the methylation of CHD6 promoter] which affects the expression of CHD6 mRNA | affects expression|affects methylation | 18577749
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of CHD6 mRNA | decreases expression | 16807920
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CHD6 mRNA | decreases expression | 19933214
|
C025643 |
vinclozolin |
vinclozolin results in increased expression of CHD6 mRNA | increases expression | 18042343
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 11752688 15322242 14514962 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.86 | 19015723 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.07 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.78 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.65 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.90 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15668235 12621046 16354765 8697196 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.67 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.56 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.33 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.74 | 16417039 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.66 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.51 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.51 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.98 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.21 | 16705839 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.19 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.28 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.41 | 18460780 19387464 19010910 18206229 17679729 18704418 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.91 | 18055864 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.13 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.61 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.27 | 16505122 17785578 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.54 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.52 | 18608210 16882708 19157545 19010910 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.25 | 18551238 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.83 | 19116145 19470736 17925555 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009447 |
Neuroblastoma |
marker/mechanism |
|
| 18577749 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.69 | 16049721 12819281 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.72 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.84 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.84 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
10.84 | 18042343 19015723 18220299 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.09 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.33 | 18220299 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.33 | 18629315 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.71 | 19155313 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.71 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.54 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.48 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.48 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 10091137 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.36 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |